Why the study?
Understanding racial and ethnic differences in patients with acute myocardial infarction is needed to lay the foundation for more equitable health care.
Are there racial and ethnic differences in risk factors, treatment, and all-cause mortality among young adults hospitalized for acute myocardial infarction?
Are there racial and ethnic differences in risk factors, treatment, and all-cause mortality among young adults hospitalized for acute myocardial infarction?
Significant racial and ethnic disparities exist in risk factors and statin adherence among young adults with AMI, though adjusted all-cause mortality differences between Black and White patients were not statistically significant.
Answers are grounded in this paper and cite their sources.
Racial/ethnic AMI disparities in young adults warrant equity-focused monitoring; observational data leave open causal mechanisms and targeted interventions.
Introduction Understanding racial/ethnic differences in patients with acute myocardial infarction (AMI) lays the foundation for more equitable health care. This study evaluated racial/ethnic differences in risk factors, treatment, and outcomes in patients with AMI. Methods This retrospective study included patients aged 18-50 years hospitalized for AMI between 2006 and 2016. Cox regression models were used to evaluate the association of race/ethnicity with all-cause mortality. Results Among 1753 patients hospitalized for type 1 AMI (median age 44 years, 85% male), 35.8% self-identified as White, 9.4% non-Hispanic Black, 37.6% Hispanic, 14.5% Asian, and 2.6% as other. Compared to White patients, Black patients were more likely to have hypertension (53.1% vs 32.2%, p < 0.001) and Hispanic patients were more likely to have diabetes (28.2% vs 15.5%, p < 0.001) and obesity (23.9% vs 17.7%, p = 0.008). There were no substantial differences in revascularization rates or initial medical treatment. However, adherence to statin therapy was lower among Black and Hispanic patients (50.3% and 58.6% for Black and Hispanic vs 67.4% and 72.3% for White and Asian patients, respectively). Over a median follow-up of 7.5 years, Black patients had higher all-cause mortality (unadjusted hazard ratio = 1.88, 95% confidence interval = 1.09-3.24) compared to White patients, but this difference was no longer significant after adjustments (adjusted hazard ratio = 1.32, 95% confidence interval = 0.74-2.36). Discussion and Conclusion There are racial/ethnic differences in risk factors and medication adherence patterns in adults with AMI. To achieve equitable care, programs with tailored intervention addressing needs of different groups should be developed.
No takes yet. Share an insight, caveat, or question.
Hammershaimb et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: